Quidel Corporation today announced they have received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to market its COVID-19 antigen test.
The test is intended for individuals who are suspected of COVID-19 within the first five days of the onset of symptoms.